Κατεβάστε εδώ το πρόγραμμα σε PDF
Saturday, 12 October 2024
08.15 - 09.00 Registrations
09.00 – 09.15 Introduction: A.G. Tzioufas - E. Andreakos
Chairs: A.G. Tzioufas
The pleiotropic effects of type III interferons in inflammation and beyond
E. Andreakos
10.00 – 11.00 Neutrophils in inflammation: New tricks for old dogs
Chairs: D. Karokis - G. Katsifis
Periodic fevers
P. Skendros
The role of NETs in inflammation
K. Kambas
11.00 – 11.15 Coffee break
11.15 – 12.30 Systemic lupus erythematosus
Chair: D. Boumpas
Remission and low disease activity in SLE
G. Bertsias
Classification criteria of SLE
M. Aringer
Management of SLE
A. Faniouriakis
Concluding remarks
D. Boumpas
12.30 – 13.30 Lecture
Chairs: G. Bertsias
Εvolving role of TNF inhibitors in Behcet’s disease
P. Sfikakis
13.30 – 15.00 Break
15.00 – 16.00 Plenary lecture
Chairs: E. Andreakos - A. Goules
Interstitial lung disease in autoimmune rheumatic diseases
O. Distler
16.00 – 17.00 Co-morbidities in autoimmune diseases
Chairs: G. Kittas - A. Georgountzos
Cardiovascular risk in rheumatoid arthritis
G. Kitas
Infections in autoimmune rheumatic diseases
D. Vassilopoulos
17.00 – 17.15 Coffee break
17.15 – 18.45 Vasculitis
Chairs: C. Salvarani - D. Vassilopoulos
New advancements in the pathogenesis of Giant cell arteritis
S. Croci
New aspects in the classification and treatment of Large Vessle Vasculitis
C. Salvarani
Senescent cells with inflammatory phenotype towards tissue injury in Giant Cell arteritis
A.G. Tzioufas
18.45 – 19.45 Plenary lecture
Treatment of Autoimmune Diseases by Chimeric Antigen Receptor (CAR) T cells
G. Schett
Sunday, 13 October 2022
09.00 – 9.45 Plenary lecture
Chair: I. Boletis
New aspects in the pathogenesis and management of ANCA Vasculitis
D. Jayne
09.45 – 11.00 Work in progress
Chairs and discussants: D. Jayne - G. Schett
M. Papadaki - Lipidomics in inflammation
E. Koronaiou - Type III Interferons and CNS disease
A. Piperakis - The expression map of the type III interferon receptor in the mouse
D. Palamidas - Integrational analysis of high-end technologies in LVV
P. Panagopoulos - Pulmonary involvement in Sjogren’s disease
E. Gavriilidis - Cross talk of NETs and fibroblasts in autoinflammation
N. Vlachogiannis - The role of tissue iron deposition in systemic sclerosis
11.00 – 11.15 Coffee break
11.15 – 12.15 Sjogren Syndrome
Chairs: A.G. Tzioufas - C. Mavragani
New Insights in the Pathogenesis of Sjogren’s Disease
A. Goules
New clinical studies in Sjogren's Disease
L. Chatzis
12.15 – 13.30 High-throughput assays to evaluate inflammatory responses
Chairs: V. Andreakos - C. Tamvakopoulos
Vascular PET-CT in low grade and acute inflammation
C. Anagnostopoulos
Plasma and tissue metabolomics in inflammatory conditions
C. Tamvakopoulos
Deep immunophenotyping in autoimmune and autoinflammatory diseases
I. Galani
13.30 - 13.45 Wrap-up
A. G. Tzioufas - E Andreakos
